WESTBROOK, Maine, Feb. 15 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (NASDAQ:IDXX), announced today that its Board of Directors has authorized the repurchase by the Company of an additional four million shares of its common stock under its ongoing share repurchase program. Repurchases will be made in the open market or in negotiated transactions. These shares are in addition to the 2,852,000 shares remaining as of December 31, 2007, under a previous Board authorization. The timing and amount of any repurchases will be at the discretion of the Company's management.
About IDEXX Laboratories IDEXX Laboratories, Inc. is a leader in companion animal health, serving practicing veterinarians around the world with innovative, technology-based offerings, including a broad range of diagnostic products and services, practice management systems and pharmaceuticals. IDEXX products enhance the ability of veterinarians to provide advanced medical care and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,500 people and offers products to customers in over 100 countries.
Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155 http://www.newscom.com/cgi-bin/prnh/20030305/IDEXXLOGO http://photoarchive.ap.org/ DATASOURCE: IDEXX Laboratories, Inc.
CONTACT: Merilee Raines, Chief Financial Officer of IDEXX Laboratories, Inc., +1-207-556-8155 Web site: http://www.idexx.com/
|